SCHEMBL3341045

SCHEMBL3341045

CCCn1nccc1-c1ccc(C)c(N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.50
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
MAPT P10636 2/20 0.37
USP2 O75604 1/20 0.37
ADRA1A P35348 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP3A4 P08684 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342517 0.81 PIK3CD (0.42) NR3C2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL3341042 0.80 NR3C2 (0.57) NR3C2RAB9ANPC1ADRA1ATDP1
SCHEMBL3344440 0.80 PIK3CD (0.52) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL24026958 0.77 NR3C2 (0.43) NR3C2CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL2609208 0.73 CYP11B1 (0.38) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL6526036 0.71 PDE3B (0.38) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL22643216 0.70 NISCH (0.44) NR3C2RAB9ANPC1ADRA1ACYP3A4
SCHEMBL21858879 0.69 NR3C2 (0.40) NR3C2ALDH1A1KDM4EMAPTADRA1A
SCHEMBL3343192 0.69 P2RX7 (0.47) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL2340816 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 NR3C2 1206/4885ALDH1A1 1506/4885KDM4E 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.